Stay updated with breaking news from Robertm Plenge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Calamos Advisors LLC reduced its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 26.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 681,613 shares of the biopharmaceutical company’s stock after selling 244,526 shares during the quarter. Calamos Advisors LLC’s holdings in Bristol-Myers Squibb […]
Tokio Marine Asset Management Co. Ltd. lifted its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 2.6% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 51,715 shares of the biopharmaceutical company’s stock after purchasing an additional 1,291 shares during the quarter. […]
Talbot Financial LLC raised its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 12.1% in the second quarter, Holdings Channel reports. The fund owned 74,685 shares of the biopharmaceutical company’s stock after buying an additional 8,078 shares during the period. Talbot Financial LLC’s holdings in Bristol-Myers Squibb were worth $4,776,000 as of its most […]
J.W. Cole Advisors Inc. lowered its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 7.4% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 26,590 shares of the biopharmaceutical company’s stock after selling 2,121 shares during the quarter. J.W. Cole Advisors Inc.’s holdings in […]
Welch & Forbes LLC trimmed its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.7% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 160,194 shares of the biopharmaceutical company’s stock after selling 2,797 shares during the period. Welch & Forbes LLC’s holdings in Bristol-Myers Squibb […]